Healthcare
Live Price
Offline$0.41
+0.00% today
1Y Change
-88.91%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Protagenic Therapeutics, Inc. (PTIX) is a Healthcare stock with listed on NASDAQ. The stock last traded around $0.41 and down 88.9% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -205.3%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -205.3%, free cash flow +1.8% with operating margin 0.0% and ROIC 379.7%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PTIX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PTIX
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PTIX Max Drawdown
-92.24%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PTIX and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
| Ex-Date | Record | Pay | Dividend | Adj | Frequency |
|---|---|---|---|---|---|
| Dec 5, 2005 | Oct 31, 2005 | — | $0.46 | $479749712.15 | Irregular |
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.